Article

Formulation decreases risk of recurrent stone formation

Orthophosphate formula (Uro-KP-Neutral) from Star Pharmaceuticals decreasesthe risk of recurrent calcium oxalate stone formation and the growth ofresidual stones following lithotripsy. In addition, the formulation is agood source of supplemental potassium, sodium, and phosphorus, accordingto the company.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

© 2025 MJH Life Sciences

All rights reserved.